Table 4 Distribution of msp1 block 2 alleles among study localities
Msp1 block 2 allele type | Clinical phenotype | Number of positives (%) | P value | |||
|---|---|---|---|---|---|---|
All subjects | Rural | Semi-rural | Semi-urban | |||
K1 | AP | 55 (90.2) | 16 (84.2) | 36 (94.7) | 3 (75.0) | 0.260 |
MAD20 | 32 (52.5) | 13 (68.4) | 18 (47.4) | 1 (25.0) | 0.170 | |
RO33 | 26 (42.6) | 14 (73.7) | 10 (26.3) | 2 (50.0) | 0.003 | |
MR | 21 (34.4) | 11 (57.1) | 9 (23.7) | 1 (25.0) | 0.034 | |
Monoclonality | 24 (39.3) | 3 (15.8) | 18 (47.8) | 3 (75.0) | 0.023 | |
Polyclonalitya | 37 (60.7) | 16 (84.2) | 20 (52.6) | 1 (25.0) | 0.023 | |
K1 + MAD20 | 14 (23.0) | 3 (15.8) | 11 (28.9) | 0 (0.0) | 0.284 | |
K1 + RO33 | 6 (9.8) | 3 (15.8) | 3 (7.9) | 0 (0.0) | 0.507 | |
MAD20 + RO33 | 2 (3.3) | 2 (10.5) | 0 (0.0) | 0 (0.0) | 0.102 | |
K1 + MAD20 + RO33 | 15 (24.6) | 8 (42.1) | 6 (15.8) | 1 (25.0) | 0.094 | |
K1 | UM | 58 (71.6) | 10 (71.4) | 30 (71.4) | 18 (72.0) | 0.999 |
MAD20 | 45 (55.6) | 9 (64.3) | 24 (57.1) | 12 (48.0) | 0.591 | |
RO33 | 38 (46.9) | 8 (57.1) | 18 (42.9) | 12 (48.0) | 0.645 | |
MR | 38 (46.9) | 6 (42.9) | 19 (45.2) | 13 (52.0) | 0.819 | |
Monoclonality | 34 (42.0) | 3 (21.4) | 21 (50.0) | 10 (40.0) | 0.167 | |
Polyclonalitya | 47 (58.0) | 11 (78.6) | 21 (50.0) | 15 (60.0) | 0.167 | |
K1 + MAD20 | 17 (21.0) | 4 (28.6) | 7 (16.7) | 6 (24.0) | 0.578 | |
K1 + RO33 | 9 (11.1) | 2 (14.3) | 2 (4.8) | 5 (20.0) | 0.145 | |
MAD20 + RO33 | 8 (9.9) | 3 (21.4) | 3 (7.1) | 2 (8.0) | 0.279 | |
K1 + MAD20 + RO33 | 13 (16.0) | 2 (14.3) | 9 (21.4) | 2 (8.0) | 0.344 | |